General principles of management of patients | p. 1 |
Communication skills | p. 2 |
Documentation and notekeeping | p. 4 |
Patient safety in surgical practice | p. 6 |
Significance and preliminary investigation of urological symptoms and signs | p. 7 |
Haematuria I: definition and types | p. 8 |
Haematuria II: causes and investigation | p. 10 |
Haemospermia | p. 12 |
Lower urinary tract symptoms (LUTS) | p. 14 |
Nocturia and nocturnal polyuria | p. 18 |
Loin (flank) pain | p. 20 |
Urinary incontinence | p. 24 |
Genital symptoms | p. 26 |
Abdominal examination in urological disease | p. 28 |
Digital rectal examination (DRE) | p. 32 |
Lumps in the groin | p. 34 |
Lumps in the scrotum | p. 36 |
Urological investigations | p. 39 |
Urine examination | p. 40 |
Urine cytology | p. 42 |
Prostatic specific antigen (PSA) | p. 44 |
Radiological imaging of the urinary tract | p. 46 |
Uses of plain abdominal radiography | p. 48 |
Intravenous urography (IVU) | p. 50 |
Other urological contrast studies | p. 54 |
Computed tomography (CT) and magnetic resonance imaging (MRI) | p. 56 |
Radioisotope imaging | p. 58 |
Uroflowmetry | p. 60 |
Post-void residual urine volume measurement | p. 64 |
Cystometry, pressure flow studies, and videocystometry | p. 66 |
Bladder outlet obstruction | p. 69 |
Regulation of prostate growth and development of benign prostatic hyperplasia (BPH) | p. 70 |
Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH | p. 72 |
Benign prostatic obstruction (BPO): symptoms and signs | p. 74 |
Diagnostic tests in men with LUTS thought to be due to BPH | p. 76 |
Why do men seek treatment for their symptoms? | p. 78 |
Watchful waiting for uncomplicated BPH | p. 80 |
Medical management of BPH: alpha blockers | p. 82 |
Medical management of BPH: 5[alpha]-reductase inhibitors | p. 84 |
Medical management of BPH: combination therapy | p. 86 |
Medical management of BPH: alternative drug therapy | p. 87 |
Minimally invasive management of BPH: surgical alternatives to TURP | p. 88 |
Invasive surgical alternatives to TURP | p. 90 |
TURP and open prostatectomy | p. 92 |
Acute urinary retention: definition, pathophysiology, and causes | p. 94 |
Acute urinary retention: initial and definitive management | p. 98 |
Indications for and technique of urethral catheterization | p. 100 |
Indications for and technique of suprapubic catheterization | p. 102 |
Management of nocturia and nocturnal polyuria | p. 104 |
High pressure chronic retention (HPCR) | p. 106 |
Bladder outlet obstruction and retention in women | p. 108 |
Urethral stricture disease | p. 110 |
Incontinence | p. 113 |
Classification | p. 114 |
Causes and pathophysiology | p. 116 |
Evaluation | p. 118 |
Treatment of sphincter weakness incontinence: injection therapy | p. 119 |
Treatment of sphincter weakness incontinence: retropubic suspension | p. 120 |
Treatment of sphincter weakness incontinence: pubovaginal slings | p. 121 |
Treatment of sphincter weakness incontinence: the artificial urinary sphincter | p. 122 |
Overactive bladder: conventional treatment | p. 124 |
Overactive bladder: options for failed conventional therapy | p. 125 |
'Mixed' incontinence | p. 126 |
Post-prostatectomy incontinence | p. 128 |
Vesicovaginal fistula (VVF) | p. 130 |
Incontinence in the elderly patient | p. 132 |
Infections and inflammatory conditions | p. 135 |
Urinary tract infection: definitions, incidence, and epidemiology | p. 136 |
Urinary tract infection: microbiology | p. 138 |
Lower urinary tract infection | p. 142 |
Recurrent urinary tract infection | p. 144 |
Urinary tract infection: treatment | p. 148 |
Acute pyelonephritis | p. 150 |
Pyonephrosis and perinephric abscess | p. 152 |
Other forms of pyelonephritis | p. 154 |
Chronic pyelonephritis | p. 156 |
Septicaemia | p. 158 |
Fournier's gangrene | p. 162 |
Epididymitis and orchitis | p. 164 |
Peri-urethral abscess | p. 166 |
Prostatitis: epidemiology and classification | p. 168 |
Prostatitis: presentation, evaluation, and treatment; prostatic abscess | p. 170 |
Interstitial cystitis | p. 172 |
Tuberculosis | p. 174 |
Parasitic infections | p. 176 |
HIV and hepatitis in urological surgery | p. 178 |
Phimosis | p. 182 |
Inflammatory disorders of the penis | p. 184 |
Urological neoplasia | p. 187 |
Molecular biology and pathology | p. 190 |
Prostate cancer: epidemiology and aetiology | p. 192 |
Prostate cancer: incidence, prevalence, and mortality | p. 194 |
Prostate cancer pathology: adenocarcinoma | p. 195 |
Prostate cancer pathology: possible premalignant lesions | p. 196 |
Prostatic specific antigen (PSA) and prostate cancer screening | p. 197 |
Prostate cancer: clinical presentation | p. 198 |
PSA and prostate cancer | p. 200 |
PSA derivatives: free-to-total ratio, density, and velocity | p. 202 |
Counselling before PSA testing | p. 203 |
Prostate cancer: transrectal ultrasonography and biopsies | p. 204 |
Prostate cancer staging | p. 208 |
Prostate cancer grading | p. 216 |
Management of localized prostate cancer: watchful waiting | p. 218 |
Management of localized prostate cancer: radical prostatectomy | p. 220 |
Post-operative course after radical prostatectomy: complications | p. 222 |
Prostate cancer control with radical prostatectomy | p. 224 |
Management of localized prostate cancer: radical external beam radiotherapy (EBRT) | p. 226 |
Management of localized prostate cancer: brachytherapy (BT) | p. 228 |
Management of localized and radio-recurrent prostate cancer: cryotherapy and HIFU | p. 230 |
Management of locally advanced non-metastatic prostate cancer (T3-4 N0M0) | p. 231 |
Management of advanced prostate cancer: hormone therapy I | p. 232 |
Management of advanced prostate cancer: hormone therapy II | p. 234 |
Management of advanced prostate cancer: hormone therapy III | p. 236 |
Management of advanced prostate cancer: androgen-independent disease | p. 238 |
Palliative management of prostate cancer | p. 240 |
Prostate cancer: prevention; complementary and alternative therapies | p. 242 |
Bladder cancer: epidemiology and aetiology | p. 244 |
Bladder cancer: pathology and staging | p. 246 |
Bladder cancer: presentation | p. 250 |
Bladder cancer: diagnosis and staging | p. 252 |
Management of superficial TCC: transurethral resection of bladder tumour (TURBT) | p. 254 |
Management of superficial TCC: adjuvant intravesical chemotherapy and BCG | p. 256 |
Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease | p. 258 |
Muscle-invasive bladder cancer: radical and palliative radiotherapy | p. 260 |
Muscle-invasive bladder cancer: management of locally advanced and metastatic disease | p. 262 |
Bladder cancer: urinary diversion after cystectomy | p. 264 |
Transitional cell carcinoma (TCC) of the renal pelvis and ureter | p. 268 |
Radiological assessment of renal masses | p. 272 |
Benign renal masses | p. 274 |
Renal cell carcinoma: epidemiology and aetiology | p. 276 |
Renal cell carcinoma: pathology, staging, and prognosis | p. 278 |
Renal cell carcinoma: presentation and investigations | p. 282 |
Renal cell carcinoma: surgical treatment I | p. 284 |
Renal cell carcinoma: surgical treatment II | p. 286 |
Renal cell carcinoma: management of metastatic disease | p. 288 |
Testicular cancer: epidemiology and aetiology | p. 290 |
Testicular cancer: clinical presentation | p. 292 |
Testicular cancer: serum markers | p. 294 |
Testicular cancer: pathology and staging | p. 296 |
Testicular cancer: prognostic staging system for metastatic germ cell cancer | p. 300 |
Testicular cancer: management of non-seminomatous germ cell tumours (NSGCT) | p. 302 |
Testicular cancer: management of seminoma, IGCN, and lymphoma | p. 304 |
Penile neoplasia: benign, viral-related, and premalignant lesions | p. 306 |
Penile cancer: epidemiology, risk factors, and pathology | p. 308 |
Squamous cell carcinoma of the penis: clinical management | p. 312 |
Carcinoma of the scrotum | p. 314 |
Tumours of the testicular adnexa | p. 315 |
Urethral cancer | p. 316 |
Retroperitoneal fibrosis | p. 320 |
Wilms' tumour and neuroblastoma | p. 322 |
Miscellaneous urological disease of the kidney | p. 325 |
Cystic renal disease: simple cysts | p. 326 |
Cystic renal disease: calyceal diverticulum | p. 328 |
Cystic renal disease: medullary sponge kidney (MSK) | p. 330 |
Acquired renal cystic disease (ARCD) | p. 332 |
Autosomal dominant (adult) polycystic kidney disease (ADPKD) | p. 334 |
Vesicoureteric reflux (VUR) in adults | p. 336 |
Pelviureteric junction (PUJ) obstruction in adults | p. 340 |
Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation | p. 342 |
Renal duplications | p. 346 |
Stone disease | p. 349 |
Kidney stones: epidemiology | p. 350 |
Kidney stones: types and predisposing factors | p. 352 |
Kidney stones: mechanisms of formation | p. 354 |
Factors predisposing to specific stone types | p. 356 |
Evaluation of the stone former | p. 358 |
Kidney stones: presentation and diagnosis | p. 362 |
Kidney stones treatment options: watchful waiting | p. 364 |
Stone fragmentation techniques: extracorporeal lithotripsy (ESWL) | p. 366 |
Intracorporeal techniques of stone fragmentation | p. 368 |
Kidney stone treatment: flexible ureteroscopy and laser treatment | p. 372 |
Kidney stone treatment: percutaneous nephrolithotomy (PCNL) | p. 374 |
Kidney stones: open stone surgery | p. 378 |
Kidney stones: medical therapy (dissolution therapy) | p. 380 |
Ureteric stones: presentation | p. 382 |
Ureteric stones: diagnostic radiological imaging | p. 384 |
Ureteric stones: acute management | p. 386 |
Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone | p. 388 |
Ureteric stone treatment | p. 390 |
Treatment options for ureteric stones | p. 392 |
Prevention of calcium oxalate stone formation | p. 394 |
Bladder stones | p. 396 |
Management of ureteric stones in pregnancy | p. 398 |
Upper tract obstruction, loin pain, hydronephrosis | p. 401 |
Hydronephrosis | p. 402 |
Management of ureteric strictures (other than PUJO) | p. 406 |
Pathophysiology of urinary tract obstruction | p. 410 |
Physiology of urine flow from kidneys to bladder | p. 412 |
Ureter innervation | p. 414 |
Trauma to the urinary tract and other urological emergencies | p. 415 |
Renal trauma: classification, mechanism, grading | p. 416 |
Renal trauma: clinical and radiological assessment | p. 420 |
Renal trauma: treatment | p. 422 |
Ureteric injuries: mechanisms and diagnosis | p. 426 |
Ureteric injuries: management | p. 428 |
Pelvic fractures; bladder and ureteric injuries associated with pelvic fractures | p. 432 |
Bladder injuries | p. 438 |
Posterior urethral injuries in males and urethral injuries in females | p. 442 |
Anterior urethral injuries | p. 444 |
Testicular injuries | p. 448 |
Penile injuries | p. 450 |
Torsion of the testis and testicular appendages | p. 452 |
Paraphimosis | p. 454 |
Malignant ureteric obstruction | p. 456 |
Spinal cord and cauda equina compression | p. 457 |
Infertility | p. 459 |
Male reproductive physiology | p. 460 |
Aetiology and evaluation of male infertility | p. 464 |
Investigation of male infertility | p. 466 |
Oligospermia and azoospermia | p. 468 |
Varicocele | p. 470 |
Treatment options for male factor infertility | p. 472 |
Disorders of erectile function, ejaculation, and seminal vesicles | p. 475 |
Physiology of erection and ejaculation | p. 476 |
Impotence: evaluation | p. 480 |
Impotence: treatment | p. 482 |
Retrograde ejaculation | p. 484 |
Peyronie's disease | p. 486 |
Priapism | p. 488 |
Neuropathic bladder | p. 491 |
Innervation of the lower urinary tract (LUT) | p. 492 |
The physiology of urine storage and micturition | p. 496 |
Bladder and sphincter behaviour in the patient with neurological disease | p. 498 |
The neuropathic lower urinary tract: the clinical consequences of storage and emptying problems | p. 500 |
Bladder management techniques for the neuropathic patient | p. 502 |
Catheters and sheaths and the neuropathic patient | p. 506 |
Management of incontinence in the neuropathic patient | p. 508 |
Management of recurrent urinary tract infections (UTIs) in the neuropathic patient | p. 510 |
Management of hydronephrosis in the neuropathic patient | p. 512 |
Bladder dysfunction in multiple sclerosis, in Parkinson's disease, after stroke, and in other neurological disease | p. 514 |
Neuromodulation in lower urinary tract dysfunction | p. 516 |
Urological problems in pregnancy | p. 517 |
Physiological and anatomical changes in the urinary tract | p. 518 |
Urinary tract infection (UTI) | p. 520 |
Hydronephrosis | p. 522 |
Paediatric urology | p. 523 |
Embryology: urinary tract | p. 524 |
Undescended testes | p. 526 |
Urinary tract infection (UTI) | p. 528 |
Vesicoureteric reflux (VUR) | p. 530 |
Ectopic ureter | p. 532 |
Ureterocele | p. 533 |
Pelviureteric junction (PUJ) obstruction | p. 534 |
Hypospadias | p. 536 |
Normal sexual differentiation | p. 538 |
Abnormal sexual differentiation | p. 540 |
Cystic kidney disease | p. 544 |
Exstrophy | p. 546 |
Epispadias | p. 547 |
Posterior urethral valves (PUVs) | p. 548 |
Non-neurogenic voiding dysfunction | p. 550 |
Nocturnal enuresis | p. 552 |
Urological surgery and equipment | p. 555 |
Preparation of the patient for urological surgery | p. 556 |
Antibiotic prophylaxis in urological surgery | p. 558 |
Complications of surgery in general: DVT and PE | p. 562 |
Fluid balance and the management of shock in the surgical patient | p. 566 |
Patient safety in the urology theatre | p. 568 |
Transurethral resection (TUR) syndrome | p. 570 |
Catheters and drains in urological surgery | p. 572 |
Guidewires | p. 578 |
Irrigating fluids and techniques of bladder washout | p. 580 |
JJ stents | p. 582 |
Lasers in urological surgery | p. 588 |
Diathermy | p. 590 |
Sterilization of urological equipment | p. 592 |
Telescopes and light sources in urological endoscopy | p. 594 |
Consent: general principles | p. 596 |
Cystoscopy | p. 598 |
Transurethral resection of the prostate (TURP) | p. 600 |
Transurethral resection of bladder tumour (TURBT) | p. 602 |
Optical urethrotomy | p. 604 |
Circumcision | p. 606 |
Hydrocele and epididymal cyst removal | p. 608 |
Nesbit's procedure | p. 610 |
Vasectomy and vasovasostomy | p. 612 |
Orchidectomy | p. 614 |
Urologocial incisions | p. 616 |
JJ stent insertion | p. 618 |
Nephrectomy and nephroureterectomy | p. 620 |
Radical prostatectomy | p. 622 |
Radical cystectomy | p. 624 |
Ileal conduit | p. 628 |
Percutaneous nephrolithotomy (PCNL) | p. 630 |
Ureteroscopes and ureteroscopy | p. 634 |
Pyeloplasty | p. 638 |
Laparoscopic surgery | p. 640 |
Endoscopic cystolitholapxy and (open) cystolithotomy | p. 642 |
Scrotal exploration for torsion and orchidopexy | p. 644 |
Basic science of relevance to urological practice | p. 647 |
Physiology of bladder and urethra | p. 648 |
Renal anatomy: renal blood flow and its regulation | p. 650 |
Renal physiology: regulation of water balance | p. 654 |
Renal physiology: regulation of sodium and potassium excretion | p. 655 |
Renal physiology: acid-base balance | p. 656 |
Urological eponyms | p. 659 |
Index | p. 665 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.